Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

ACST-2 collaborators

Asymptomatic Carotid Surgery Trial 2 (ACST-2) is a large international randomised trial comparing carotid endarterectomy (CEA) versus carotid artery stenting (CAS) in patients with asymptomatic carotid stenosis where there is substantial uncertainty as to which treatment is more appropriate. ACST-2 seeks to compare these procedures and their benefit in stroke prevention.

ACST-2 is currently recruiting patients from over 112 centres in over 20 countries worldwide. The trial is on track to recruit 3600 patients by 2019. This will allow for a meaningful comparison between surgery and stenting in Asymptomatic patients with narrowing in the carotid arteries.

Our team

Related research themes